IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody
Conclusion:
IdeS may represent a groundbreaking new method of desensitization for patients who otherwise might have no hope for receiving a lifesaving transplant.
Source: Annals of Surgery - Category: Surgery Tags: Papers of the 138Th ASA Annual Meeting Source Type: research
More News: Bone Graft | Gammagard Liquid | Kidney Transplant | Kidney Transplantation | Privigen | Surgery | Transplant Surgery | Transplants | Urology & Nephrology